William Brinkman, MD, Principal Investigator
Sponsored by Medtronic, the purpose of this study is to evaluate the safety and effectiveness of the Valiant Thoracic Stent Graft System in the treatment of acute, complicated Type B aortic dissections (a tear in the lining of the aorta) in the section of the aorta that lies in the chest. The OPTION Trial—David O. Moore, MD, and Lonnie Ginn, PA, Principal Investigators icon for option trial
For many patients, clinical research offers early access to emerging therapies and advanced technology. The staff and physicians at Baylor Scott & White Cardiac Surgery Specialists are committed to delivering improved cardiovascular medical care through new and innovative therapies.
Our physicians participate in important national and international clinical trials and embrace every opportunity to provide patients with advanced drug and treatment options. Our goal is to offer a variety of clinical trials that are broad enough to afford every patient the opportunity to access today’s medical breakthroughs as they occur.